Paratek Pharmaceuticals (NASDAQ:PRTK) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM.
Here’s what investors need to know about the announcement.
Earnings
Paratek Pharmaceuticals missed estimated earnings by 6.06%, reporting an EPS of $-0.35 versus an estimate of $-0.33.
Revenue was up $6.38 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.22 which was followed by a 4.05% increase in the share price the next day.
Here’s a look at Paratek Pharmaceuticals’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.09 | -0.29 | -0.34 | -0.35 |
| EPS Actual | -0.13 | -0.38 | -0.33 | -0.35 |
| Revenue Estimate | 63.45M | 34.19M | 29.17M | 27.15M |
| Revenue Actual | 75.60M | 30.21M | 29.64M | 24.86M |
To track all earnings releases for Paratek Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
